drugset / Trial / NCT00418587
Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)
Phase 1
Completed
18 enrolled
Medical University of South Carolina
American College of Rheumatology Research and Education Foundation · collabNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety and effectiveness of different doses of vitamin D in patients with Systemic Lupus Erythematosus (SLE). A long term goal is to determine if vitamin D could be used as a treatment and/or preventative of SLE.
Timeline
- Start
- 2006-12
- Primary completion
- 2008-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 800 iu | Oral |
| Subject | Cholecalciferol | Other / unclassified | 2000 iu | Oral |
| Subject | Cholecalciferol | Other / unclassified | 4000 iu | Oral |